• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺酸性磷酸酶(PAP)和前列腺特异性抗原(PSA)对前列腺癌患者诊断价值的比较研究。

A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.

作者信息

van Dieijen-Visser M P, Delaere K P, Gijzen A H, Brombacher P J

机构信息

Department of Clinical Chemistry, De Wever-Hospital, Heerlen, The Netherlands.

出版信息

Clin Chim Acta. 1988 May 31;174(2):131-40. doi: 10.1016/0009-8981(88)90380-4.

DOI:10.1016/0009-8981(88)90380-4
PMID:2454767
Abstract

Serum prostatic-specific antigen (PSA) and prostatic acid phosphatase (PAP) were determined simultaneously in 241 patients presented to the Urology Department. The patients consisted of 140 prostatic carcinoma patients (34 newly diagnosed and 106 previously treated) and 101 patients with benign prostatic hypertrophy (BPH). Prostatic acid phosphatase was measured by two different methods, an enzymatic method (PAP-EA, Boehringer) with tartrate inhibition and an immunoenzymetric assay (PAP-IEMA, Hybritech). The concentration of prostatic specific antigen in serum was measured using a recently introduced immunoradiometric assay (PSA-IRMA, Hybritech). Receiver operating characteristic curves were constructed to compare the diagnostic value of the different tests at different cutoff values. The diagnostic efficiencies of the PAP-EA and the PAP-IEMA appeared to be similar. A better diagnostic efficiency for PSA compared to PAP was found independent of the cutoff value. The upper-normal limit of 2.7 micrograms/l for PSA, as suggested by the manufacturer and mentioned in the literature introduces too many false-positive results. We therefore selected 10 micrograms/l as the upper-normal limit for PSA (sensitivity 57%, specificity 88%). Combined sensitivity found for PAP + PSA was 37% with a specificity of 97%. A literature survey is included to allow better comparison with data published elsewhere.

摘要

对241名泌尿外科就诊患者同时测定了血清前列腺特异性抗原(PSA)和前列腺酸性磷酸酶(PAP)。患者包括140例前列腺癌患者(34例新诊断患者和106例既往接受过治疗的患者)以及101例良性前列腺增生(BPH)患者。采用两种不同方法测定前列腺酸性磷酸酶,一种是酶法(PAP-EA,勃林格公司),有酒石酸盐抑制作用,另一种是免疫酶测定法(PAP-IEMA,Hybritech公司)。血清中前列腺特异性抗原的浓度采用最近推出的免疫放射测定法(PSA-IRMA,Hybritech公司)进行测定。构建了受试者工作特征曲线,以比较不同检测方法在不同临界值时的诊断价值。PAP-EA和PAP-IEMA的诊断效率似乎相似。发现PSA的诊断效率优于PAP,且与临界值无关。制造商建议并在文献中提及的PSA正常上限2.7微克/升会产生过多假阳性结果。因此,我们选择10微克/升作为PSA的正常上限(敏感性57%,特异性88%)。PAP + PSA的联合敏感性为37%,特异性为97%。纳入了文献综述以便与其他地方发表的数据进行更好的比较。

相似文献

1
A comparative study on the diagnostic value of prostatic acid phosphatase (PAP) and prostatic specific antigen (PSA) in patients with carcinoma of the prostate gland.前列腺酸性磷酸酶(PAP)和前列腺特异性抗原(PSA)对前列腺癌患者诊断价值的比较研究。
Clin Chim Acta. 1988 May 31;174(2):131-40. doi: 10.1016/0009-8981(88)90380-4.
2
Is prostate-specific antigen the most useful marker for screening in prostate cancer?前列腺特异性抗原是前列腺癌筛查中最有用的标志物吗?
Am J Clin Oncol. 1988;11 Suppl 2:S65-7. doi: 10.1097/00000421-198801102-00015.
3
Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.未治疗的前列腺癌和良性前列腺增生中前列腺特异性抗原和前列腺酸性磷酸酶的评估。
Scand J Urol Nephrol Suppl. 1991;138:97-103.
4
The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer.与血清前列腺特异性抗原(PSA)和前列腺酸性磷酸酶(PAP)相比,尿转铁蛋白在前列腺癌患者中的诊断价值。
Clin Chim Acta. 1988 Sep 30;177(1):77-80. doi: 10.1016/0009-8981(88)90309-9.
5
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen.前列腺特异性抗原单克隆免疫放射分析方法的评估
Clin Chem. 1987 Dec;33(12):2257-61.
6
[A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].[前列腺酸性磷酸酶与前列腺特异性抗原在前列腺癌诊断中的比较]
Ned Tijdschr Geneeskd. 1990 Aug 18;134(33):1596-600.
7
Evaluation of prostate-specific antigen in untreated prostatic carcinoma.未经治疗的前列腺癌中前列腺特异性抗原的评估。
Eur Urol. 1989;16(4):253-7. doi: 10.1159/000471586.
8
Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.前列腺酸性磷酸酶和前列腺特异性抗原在前列腺癌患者中的诊断价值。
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):85-7.
9
Prostate specific antigen and prostatic acid phosphatase for monitoring therapy of carcinoma of the prostate.前列腺特异性抗原和前列腺酸性磷酸酶用于监测前列腺癌的治疗。
J Urol. 1991 Oct;146(4):1064-7; discussion 1067-8. doi: 10.1016/s0022-5347(17)38001-1.
10
Prostate-specific antigen (PSA) in the management of 500 prostatic patients.前列腺特异性抗原(PSA)在500例前列腺疾病患者管理中的应用
Am J Clin Oncol. 1988;11 Suppl 2:S61-2. doi: 10.1097/00000421-198801102-00013.

引用本文的文献

1
Neuroendocrine differentiation of prostate cancer: a review.前列腺癌的神经内分泌分化:综述
Am J Clin Exp Urol. 2014 Dec 9;2(4):273-85. eCollection 2014.
2
The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor.含94个氨基酸残基的前列腺分泌蛋白(PSP94)作为前列腺肿瘤血清标志物的潜在用途。
Urol Res. 1993 May;21(3):227-33. doi: 10.1007/BF00590041.